Clinical outcome measures of specific immunotherapy;Klinische erfolgsparameter bei der spezifischen immuntherapie

Allergo Journal

Volumn 16, Issue 8, 2007, Pages 576-581

  Pfaar, Oliver ^a,b   Klimek, Ludger ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b ZENTRUM FÜR RHINOLOGIE UND ALLERGOLOGIE   (Germany)

Author keywords

Allergic rhinitis; Clinical studies; Quality of life; Specific immunotherapy (SIT)

Indexed keywords

CELL ADHESION MOLECULE; EOSINOPHIL CATIONIC PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 5; LEUKOTRIENE; TRYPTASE;

ALLERGIC RHINITIS; ASTHMA QUALITY OF LIFE QUESTIONNAIRE; ASTHMA QUESTIONNAIRE 20; ASTHMA QUESTIONNAIRE 30; CLINICAL STUDY; DISEASE MARKER; DRUG USE; EVALUATION; HUMAN; IMMUNOTHERAPY; METHODOLOGY; MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE; MINI RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; MUCOSAL IMMUNITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PARAMETER; PRICK TEST; PROVOCATION TEST; QUALITY OF LIFE; REVIEW; RHINASTHMA; RHINASTHMA GERMAN ADAPTED VERSION; RHINOCONJUNCTIVITIS QUALITY OF LIFE QUESTIONNAIRE; SERODIAGNOSIS; SHORT FORM 20; SHORT FORM 36; SPECIFIC IMMUNOTHERAPY; SPIROMETRY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS; VISUAL ANALOG SCALE;

EID: 38949183322     PISSN: 09418849     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03361700     Document Type: Review

References (27)

1. Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S, Braido F, Bonini S, Majani G, Canonica GW. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003; 58: 289-94
2. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998; 92: 1207-14
3. Biló BM, Ruëff F, Mosbech H, Bonifazi F, Oude-Elberink JN, the EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339-49
4. Bousquet J, Malling HJ, Lockey RF. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-62
5. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-4
6. Bullinger M, Kirchberger I. SF-36, Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe, 1998
7. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, Passalacqua, Potter P, Valovirta E. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of the WAO Taskforce. Allergy 2007; 62: 317-24
8. Carver DJ, Chapman CA, Thomas VS, Stadnyk KJ, Rockwood K. Validity and reliability of the Medical Outcomes Study Short Form-20 questionnaire as a measure of quality of life in elderly people living at home. Age Ageing 1999; 28: 169-74
9. Ciprandi G, Canonica WG, Grosclaude M, Ostinelli J, Brazzola GG, Bousquet J. Effects of budesonide and fluticasone propionate in a placebo-controlled study on symptoms and quality of life in seasonal allergic rhinitis. Allergy 2002; 57: 586-91
10. Ciprandi G, Klersy C, Cirillo I, Marseglia GL. Quality of life in allergic rhinitis. Relationship with clinical, immunological and functional aspects. Clin Exp Allergy 2007; 37: 1528-35
11. Committee for Medical Products for Human Use (CHMP). Guideline on the development of products for specific immunotherapy for the treatment of allergic diseases. London, UK: EMEA, 2007 (http://www.emea.europa.eu)
12. Fisher L, Ghaffari G, Davies M, Craig T. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol 2005; 5: 11-6
13. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83
14. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14: 32-8
15. Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83
16. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999; 104: 364-9
17. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000; 30: 132-40
18. Majani G, Baiardini I, Giardini A, Senna GE, Minale P, Ulisse S D', Ciprandi G, Canonica GW. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 2001; 56: 313-7
19. Malling HJ. Criteria for clinical efficacy - readout and monitoring of clinical studies. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 2003; 94: 119-25
20. Malling HJ, Weeke B. Position paper immunotherapy of the EAACI. Allergy 1993; 48: 9-35
21. Mösges R, Schmalz P, Köberlein J, Kaciran M, Baiardini I. [The RHINASTHMA-Quality of Life Scale German Adapted Version: validation of a new disease specific quality of life scale for patients suffering from allergic rhinitis and bronchial hyperreactivity.] HNO 2007; 55: 357-64
22. Prasad M, Wahlqvist P, Shikiar R, Shih YC. A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective. Pharmacoeconomics 2004; 22: 225-44
23. Przybilla B, Ruëff F, Fuchs T, Pfeiffer C, Rakoski J, Stolz W, Vieluf D. Insektengiftallergie. Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAI). Allergo J 2004; 13: 186-90
24. Riechelmann H, Bachert C, Goldschmidt O, Hauswald B, Klimek L, Schlenter WW, Tasman AI, Wagenmann M. Durchführung des nasalen Provokationstests bei Erkrankungen der oberen Atemwege. Allergo J 2002; 11: 29-36
25. Schipper H, Clinch J, Powell V. Definitions and conceptual issues. In: Spilker B, ed. Quality of Life Assessment in Clinical Trials. New York: Raven Press, 1990: 11-24
26. Virchow JC. Asthma, allergische Rhinitis, Sinusitis. Konzept der "vereinigten Atemwege". HNO 2005; 53 (Suppl 1): 16-20
27. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83